Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2022-07-05 00:00:00 ET · period of report 2022-07-05 · accession 0001209191-22-040608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-05 | 2022-07-05 | VRCA | White Ted | Pres, CEO, Dir | P - Purchase | $2.10 | +23.8K | 29.5K | +421% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-05 | P | A | 23,809 | $2.10 | 29,466 | D | — | — |